# US 2012/0253260 A1 · Gastrointestinal prostheses

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0253260 A1
- Document ID: US20120253260A1
- Status: Published application
- Kind: A1
- Application number: 13/494,956
- Filed: 2012-06-12
- Published: 2012-10-04
- Earliest claimed: 2009-04-03
- Assignees: MetaModix, Inc.
- Inventors: Kedar R. Belhe; Paul J. Thompson
- Web page: https://patentgrep.com/patent/US20120253260A1

## CPC

- A61F 5/0076: {preventing normal digestion, e.g. Bariatric or gastric sleeves}
- A61F 5/0079: {Pyloric or esophageal obstructions}
- A61F 2002/044: {Oesophagi or esophagi or gullets}
- A61F 2002/045: {Stomach, intestines}
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

A system for therapy within a gastrointestinal system includes anchoring or attachment functionality embodied in a low-profile implant technology and removable therapy components, which can be reversibly attached to these low-profile implants to accomplish various therapies. This design allows the physician to tailor the therapy to the patient's needs. The system has the potential to create conduits for diversion and/or restriction of food and organ secretions and to facilitate the treatment of metabolic disorders such as obesity and T2DM.

## Claims

### Claim 1

An implant for treating metabolic disorders such as diabetes and obesity, the implant comprising:
an anchoring element including an expandable structure having a first portion configured for engaging a first wall of the pylorus at a first location adjacent the pyloric antrum and a second portion configured for engaging a second wall of the pylorus at a second location adjacent the duodenal bulb;
the anchoring element including a neck portion adapted to extend through and engage an inner surface of the pylorus; and
a therapy implant adapted for placement within the duodenum, the therapy implant coupled to the anchoring element, such that the therapy implant does not penetrate into or exert a radial force upon the duodenal bulb.

### Claim 2 (depends on 1)

The implant of claim 1 wherein the second portion of the anchoring element has an unconstrained diameter smaller than a duodenal bulb diameter, such that the second portion would not contact the duodenal bulb upon implantation.

### Claim 3 (depends on 1)

The implant of claim 1 wherein the second portion of the anchoring element has an unconstrained diameter larger than a duodenal bulb diameter, such that at least a portion of the second portion would contact at least a portion of the duodenal bulb upon implantation.

### Claim 4 (depends on 1)

The implant of claim 1 wherein the second portion is at least partially covered with a sleeve element that extends into the duodenum or the proximal jejunum.

### Claim 5 (depends on 1)

The implant of claim 1 wherein the neck portion is made from a flexible material configured to at least partially collapse in response to a radial force typically applied by a pylorus to allow unconstrained closing of the pylorus.

### Claim 6 (depends on 1)

The implant of claim 1 wherein the neck portion is made from a material configured to have an unconstrained diameter smaller than a maximum diameter of the pylorus, such that the neck portion acts to restrict flow through the pylorus.

### Claim 7 (depends on 1)

The implant of claim 1 wherein the second portion includes a plurality of circumferential openings configured to function as a docking feature and further wherein the therapy implant includes a plurality of circumferentially disposed protrusions configured to mate with the plurality of openings, such that the therapy implant is releasably coupled to the anchoring element to facilitate removal of the therapy implant.

### Claim 8 (depends on 1)

The implant of claim 1 wherein the neck portion is made from a material configured to have an unconstrained diameter greater than a minimum diameter of the pylorus, such that the neck portion acts to enhance flow through the pylorus.

### Claim 9

An implant for treating metabolic disorders such as diabetes and obesity, the implant comprising:
an anchoring element including an expandable structure having a first portion configured for positioning within the pyloric antrum and for engaging a proximal wall of the pylorus and a second portion configured for positioning within the duodenum and for engaging a distal wall of the pylorus;
the anchoring element including a neck portion adapted to extend through and engage an inner surface of the pylorus; and
a therapy implant adapted for placement within the duodenum, the therapy implant having a length such that it extends into the duodenum or proximal jejunum;
wherein neither of the anchoring element or the therapy implant penetrate into or exert a radial force upon the duodenal bulb.

### Claim 10 (depends on 9)

The implant of claim 9 wherein the second portion is at least partially covered with a sleeve element that extends into the duodenum or the proximal jejunum.

### Claim 11 (depends on 9)

The implant of claim 9 wherein the neck portion is made from a flexible material configured to at least partially collapse in response to a radial force typically applied by a pylorus to allow unconstrained closing of the pylorus.

### Claim 12 (depends on 9)

The implant of claim 9 wherein the neck portion is made from a material configured to have an unconstrained diameter smaller than a maximum diameter of the pylorus, such that the neck portion acts to restrict flow through the pylorus.

### Claim 13 (depends on 9)

The implant of claim 9 wherein the neck portion is made from a material configured to have an unconstrained diameter greater than a minimum diameter of the pylorus, such that the neck portion acts to enhance flow through the pylorus.

### Claim 14 (depends on 9)

The implant of claim 9 wherein the second portion includes a plurality of circumferential and further wherein the therapy implant includes a plurality of circumferentially disposed protrusions configured to mate with the plurality of openings, such that the therapy implant is releasably coupled to the anchoring element to facilitate removal of the therapy implant.

### Claim 15 (depends on 9)

The implant of claim 9 wherein the second portion of the anchoring element has an unconstrained diameter smaller than a duodenal bulb diameter, such that the second portion would not contact the duodenal bulb upon implantation.

### Claim 16 (depends on 9)

The implant of claim 9 wherein the second portion of the anchoring element has an unconstrained diameter smaller than a duodenal bulb diameter, such that the second portion would not contact the duodenal bulb upon implantation.

### Claim 17 (depends on 9)

The implant of claim 9 wherein the second portion of the anchoring element has an unconstrained diameter larger than a duodenal bulb diameter, such that at least a portion of the second portion would contact at least a portion of the duodenal bulb upon implantation.

### Claim 18

An implant for treating metabolic disorders such as diabetes and obesity, the implant comprising:
an anchoring element including an expandable structure having a first portion configured for positioning within the pyloric antrum and for engaging a proximal wall of the pylorus and a second portion configured for positioning within the duodenum and for engaging a distal wall of the pylorus;
the anchoring element including a neck portion adapted to extend through and engage an inner surface of the pylorus; and
a therapy implant adapted for placement within the duodenum, the therapy implant having a length such that it extends into the duodenum or proximal jejunum;
wherein neither of the anchoring element or the therapy implant penetrate into or exert a radial force upon the duodenal bulb; and
further wherein the first portion is disk-shaped and has an first unconstrained outer diameter larger than a second unconstrained outer diameter of the second portion.

### Claim 19 (depends on 18)

The implant of claim 18 wherein the first unconstrained outer diameter of the first portion is larger than the pyloric antrum diameter, such that at least a portion of the first unconstrained outer diameter would contact at least a portion of the pyloric antrum upon implantation.

### Claim 20 (depends on 18)

The implant of claim 18 wherein the first unconstrained outer diameter of the first portion is smaller than the pyloric antrum diameter, such that the first unconstrained outer diameter would not contact the pyloric antrum upon implantation.
